ask="4.18"
ask_size="600"
average_daily_volume="195995"
bid="3.94"
bid_size="100"
book_value="0.74"
change="+0.54"
change_from_200_day_moving_average="1.17"
change_from_50_day_moving_average="1.01"
change_from_52_week_high="-0.32"
change_From_52_week_low="2.47"
change_in_percent="+15.93%"
close="3.93"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-1.11"
ebitda="-30.33M"
eps_estimate_current_year="-1.14"
eps_estimate_next_quarter="-0.23"
eps_estimate_next_year="-0.96"
ex_dividend_date="N/A"
float_shares="19694000"
high="4.25"
high_52_weeks="4.25"
last_trade_date="2/17/2017"
last_trade_price="3.93"
last_trade_size="400"
last_trade_time="4:00pm"
low="3.38"
low_52_weeks="1.46"
market_capitalization="134.20M"
moving_average_200_day="2.76"
moving_average_50_day="2.92"
name="Fate Therapeutics
Inc."
notes="N/A"
one_year_target_price="5.83"
open="3.39"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+42.55%"
percent_change_from_50_day_moving_average="+34.60%"
percent_change_from_52_week_high="-7.53%"
percent_change_from_52_week_low="+169.18%"
previous_close="3.39"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="4.56"
price_per_sales="26.01"
revenue="4.45M"
shares_outstanding="34148000"
short_ratio="3.19"
stock_exchange="NGM"
symbol="FATE"
volume="2600618"
weeks_range_52="1.46 - 4.25"
